About Arc Trinova
Arc Trinova is a company based in Alnwick (United Kingdom) founded in 2016 was acquired by Quotient Sciences in February 2021.. Arc Trinova has raised $6.64 million across 3 funding rounds from investors including Quotient Sciences, UK Research and Innovation and BGF. Arc Trinova operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Alnwick, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.64 M (USD)
in 3 rounds
-
Latest Funding Round
$1.28 M (USD), Grant
Dec 07, 2018
-
Investors
Quotient Sciences
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Quotient Sciences
(Feb 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Arc Trinova
Arc Trinova has successfully raised a total of $6.64M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.28 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.3M
-
First Round
First Round
(21 Feb 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Grant - Arc Trinova | Valuation |
investors |
|
| Jun, 2018 | Amount | Series A - Arc Trinova | Valuation | BGF |
|
| Feb, 2017 | Amount | Debt – Conventional - Arc Trinova | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arc Trinova
Arc Trinova has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Quotient Sciences, UK Research and Innovation and BGF. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Founded Year | Domain | Location | |
|
Research and innovation funding is managed for UK advancement.
|
Founded Year | Domain | Location | |
|
APIs and finished dosage forms are developed and manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arc Trinova
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Arc Trinova
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arc Trinova Comparisons
Competitors of Arc Trinova
Arc Trinova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arc Trinova
Frequently Asked Questions about Arc Trinova
When was Arc Trinova founded?
Arc Trinova was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Arc Trinova located?
Arc Trinova is headquartered in Alnwick, United Kingdom.
Is Arc Trinova a funded company?
Arc Trinova is a funded company, having raised a total of $6.64M across 3 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $933.15K, raised on Feb 21, 2017.
What does Arc Trinova do?
Arc Trinova was established in 2016 and is headquartered in Alnwick, United Kingdom. Operations focus on the life sciences sector, where contract manufacturing for pharmaceutical products is handled alongside bioanalytical testing and regulatory consulting. Services support drug development processes, including formulation, stability analysis, and compliance advisory. The company serves clients across Europe through its integrated facilities and expertise in outsourced solutions.
Who are the top competitors of Arc Trinova?
Arc Trinova's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Who are Arc Trinova's investors?
Arc Trinova has 3 investors. Key investors include Quotient Sciences, UK Research and Innovation, and BGF.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.